RARECELLS INC.

In News

Rarecells Inc. Appoints Dr. Neil Kurtz to Board of Directors - PR Newswire

PR Newswire - Mar 26, 2025

Rarecells unveils new clinical data highlighting enhanced sensitivity in early-stage lung cancer detection - SelectScience

SelectScience - Sep 15, 2025

Rare Cell Isolation Market Size, Share & Growth Report by 2034 - Straits Research

Straits Research - Dec 08, 2025

Rarecells, Inc. announces successful Series A funding, reaching $13 Million raised to develop Liquid Biopsy Early Cancer Detection Tests - BioSpace

BioSpace - Dec 09, 2021

Rarecells, Inc. announces a breakthrough publication on Circulating Giant Cancer Cells detected in patients with MDS - BioSpace

BioSpace - Jul 20, 2023

Incorporation of lateral microfiltration with immunoaffinity for enhancing the capture efficiency of rare cells - Nature

Nature - Aug 26, 2020

The DGIST increases clinical diagnosis accuracy through the development of rare cell loss minimization technology. - Asia Research News |

Asia Research News | - May 11, 2023

ISET® technology makes Circulating Tumor Cells accessible to target PDAC mutant genes detection in pancreatic cancer with an accuracy demonstrated by a targeted scNGS - Newswire Canada

Newswire Canada - Apr 06, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment